Counselors in Sun Valley, NV Accepting Medicare
3 Counselors found. Showing 1 - 3
 Natali Perez, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 5647 Cranberry Ct, Sun Valley, NV 89433 Phone: 775-240-8070 |
Brigit Ann Mcgurk Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3775 Moorpark Ct, Sun Valley, NV 89433 Phone: 702-677-1809 |
Michelle Lee Zeigler, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 5856 Lupin Dr, Sun Valley, NV 89433 Phone: 775-348-8811 Fax: 775-348-8830 |
News Archive
Shire announces FDA PDUFA date for FIRAZYR NDA in treatment of acute attacks of hereditary angioedema
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
Closer to the root cause of diabetes
A new research discovery published online in the FASEB Journal (http://www.fasebj.org) may change the perception and treatment of diabetes. That's because scientists have moved closer toward correcting the root cause of the disease rather than managing its symptoms. Specifically researchers identified a protein (G6PD protein) and its antioxidant product (NAPDH) that both prevent the death and promote the growth of cells which produce and release insulin in the pancreas (beta cells).
First Edition: December 13, 2013
Today's early morning highlights from the major news organizations, including reports about a set of steps taken by the Obama administration in an effort to help consumers avoid coverage lapses as the health law takes effect.
New general manager's banking background beneficial at Global Fund
In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, a research fellow and director of global health policy at CGD, explains why the banking background of the new general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gabriel Jaramillo, "should serve him well."
Mannitol improves effectiveness of HUCBs in neonatal rat models of cerebral palsy
The sugar-alcohol compound mannitol improved the therapeutic effectiveness of human umbilical cord blood cells injected into neonatal rat models of cerebral palsy, reports a new international study led by the University of South Florida. The mannitol opened the blood-brain barrier by temporarily shrinking the tight endothelial cells that make up the barrier.
› Verified 3 days ago